CSE Bulletin: Consolidation - NeonMind Biosciences Inc. (NEON)

Toronto, Ontario--(Newsfile Corp. - le 14 avril/April 2022) - NeonMind Biosciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every four (4) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 32,144,140 common shares.

The name and symbol will not change.

Please note that all open orders will be cancelled at the close of business on April 14, 2022. Dealers are reminded to re-enter their orders taking into account the share consolidation.

_________________________________

NeonMind Biosciences Inc. a annoncé une consolidation de ses actions ordinaires émises et en circulation sur la base d'une (1) action ordinaire post-consolidée pour quatre (4) actions ordinaires pré-consolidées.

En conséquence, les actions en circulation de la société seront réduites à environ 32 144 140 actions ordinaires.

Le nom et le symbole ne changeront pas.

Veuillez noter que tous les ordres ouverts seront annulés à la fermeture des bureaux le 14 avril 2022. Il est rappelé aux concessionnaires de saisir à nouveau leurs ordres en tenant compte du regroupement d'actions.

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: [email protected]

Pour toute question ou information complémentaire, veuillez contacter Listings au 416 367-7340 ou par courriel à: [email protected]

You May Also Be Interested In

• Atlantico Identifies Strong Gallium Associations With Niobium, Titanium and Vanadium at Flagship Novo Cruzeiro Project
• Grand Rapids Housing Commission Featured on "All Access hosted by Andy Garcia" for Innovative Approach to Affordable Housing
• XDI and Veridion unlock a new era of company climate risk analysis